LMMY Exousia Bio, Inc.

CIK 0001939937 4 ready 8-Ks latest November 17, 2025, 6:59 PM ET RSS · JSON

Activity: NORMAL 0 filings / 30d vs 0 baseline

Ready 8-Ks 4

Latest filing November 17, 2025, 6:59 PM ET

Top materiality 0.95

Event mix leadership ×2 · m_and_a ×1 · other_material ×1

Sentiment 0 pos · 0 neg · 4 neu

Executive change recent →

Recent 8-K filings for LMMY

Highest-materiality recent filing

LAMY acquires Exousia Ai in reverse merger; appoints Matthew Dwyer as sole officer and director

November 17, 2025, 6:59 PM ET M&A materiality 0.95 neutral item 1.01 item 5.01 item 2.01 item 3.02 item 5.02 item 9.01 ◈ M&A Transactions

Closed acquisition of Exousia Ai, issuing 62,223,000 shares of common stock to Exousia Ai shareholders.
Zhang Shengwu resigned as sole officer/director; Matthew Dwyer appointed as replacement effective November 17, 2025.

Read filing →

November 17, 2025, 6:59 PM ET M&A materiality 0.95 neutral item 1.01 item 5.01 item 2.01 item 3.02 item 5.02 item 9.01 ◈ M&A Transactions

LAMY acquires Exousia Ai in reverse merger; appoints Matthew Dwyer as sole officer and director

Closed acquisition of Exousia Ai, issuing 62,223,000 shares of common stock to Exousia Ai shareholders.
December 17, 2024, 6:59 PM ET leadership materiality 0.70 neutral item 5.01 item 5.02 ◈ M&A Transactions

Zhang Shengwu acquires 64.29% of LAMY, becomes sole director and CEO

Zhang Shengwu purchased 5,250,000 shares (64.29% voting control) for $335,910 from Witmer and Townsend.

Executive changes

Appointed

Stephen Edward Townsend

Chief Operating Officer

LMMY · Exousia Bio, Inc.

Effective: 2023-03-15
Filed: March 17, 2023, 7:59 PM ET

On March 15, 2023, the board of directors (the “Board”) of LAMY (the “Company”) appointed Mr. Stephen Edward Townsend, to the Board as Chief Operating Officer.

Materiality & sentiment trend

Max materiality 0.95 · Median 0.55 · Most common event leadership

0 positive 0 negative 4 neutral

source · LMMY on sec.gov